DexCom Announces Strong Growth Outlook, Shares Rise
DexCom (DXCM) announced a revised growth outlook for annual organic revenue of 10% through 2030 and raised its non-GAAP margin targets. The stock rose 6.59%, snapping a two-day losing streak.
Tickers: $DXCM
Topics: board changes DexCom revenue guidance stock performance